<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00165022</url>
  </required_header>
  <id_info>
    <org_study_id>GQOL</org_study_id>
    <nct_id>NCT00165022</nct_id>
  </id_info>
  <brief_title>Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population</brief_title>
  <official_title>Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <brief_summary>
    <textblock>
      A questionnaire composed of items addressing psychological, emotional and social aspects of&#xD;
      GERD is developed for Chinese population. We plan to conduct a validation study on this novel&#xD;
      disease-specific quality of life (QoL) instrument. This study aims to evaluate various&#xD;
      indicators of validity and reliability, which include criterion validity, test-retest&#xD;
      reliability, responsiveness, internal consistency reliability and discriminant validity.&#xD;
&#xD;
      After initial pilot testing of face validity and content validity, two hundred GERD patients&#xD;
      from the gastroenterology and ulcer clinics of cluster NTE hospitals will be invited to&#xD;
      complete a revised 18-item version of GERD-QOL questionnaire. The data from GERD QOL will be&#xD;
      evaluated using exploratory factor analysis to identify appropriate items and domains and the&#xD;
      internal consistency of the domains will be determined and further refinement of&#xD;
      questionnaire will follow.&#xD;
&#xD;
      100 GERD patients will complete GERD-QOL, SF-36 health survey and the visual analog scale&#xD;
      (VAS) questionnaire for criterion validation. 100 GERD patients with stable symptom profile&#xD;
      will repeat GERD QOL two weeks after the first administration for evaluation of test-retest&#xD;
      reliability.&#xD;
&#xD;
      Another 26 patients who are receiving maintenance acid suppressive therapy and in remission&#xD;
      of symptom will be recruited as controls for comparison with active reflux patients. The&#xD;
      ability to distinguish active patients from controls in remission is known as discriminant&#xD;
      validity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <completion_date type="Actual">October 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <enrollment type="Actual">330</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients presenting with 1 attack of heartburn and/or acid regurgitation per week as&#xD;
             chief complaint in recent 6 months&#xD;
&#xD;
        Exclusion Criteria:Patients with&#xD;
&#xD;
          -  GERD as GI involvement of systemic disease e.g. scleroderma, SLE, thyrotoxicosis,&#xD;
             chronic intestinal pseudo-obstruction&#xD;
&#xD;
          -  Cause of esophagitis other than GERD e.g. drug induced, infection, nasogastric tube&#xD;
             injury&#xD;
&#xD;
          -  Previous gastrointestinal or hepatobiliary surgery (including cholecystectomy)&#xD;
&#xD;
          -  Organic pathology of upper GI tract that may present as reflux / dyspeptic symptom&#xD;
             e.g. peptic ulcer, gastric cancer, gastric outlet obstruction&#xD;
&#xD;
          -  Presence of alarm symptom that does not suggest functional GI disorder&#xD;
&#xD;
          -  Use of NSAID in recent 4 weeks (Low dose aspirin &lt; 300 mg is allowed)&#xD;
&#xD;
          -  Pregnant woman or lactating female&#xD;
&#xD;
          -  Illiterate patient (who cannot administer questionnaire)&#xD;
&#xD;
          -  Known hypersensitivity to PPI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justin CY WU, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Endoscopy Centre, Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2008</verification_date>
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2005</study_first_posted>
  <last_update_submitted>March 27, 2008</last_update_submitted>
  <last_update_submitted_qc>March 27, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Esophagitis, Peptic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

